NEWS
View news from our Featured Companies.
Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome
ENGLEWOOD, CO / July 20, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the initiation of the global Phase 3 PREVEnt (Prevention of Ruptures with Enzastaurin for...
Jewett-Cameron Announces 3rd Quarter Financial Results
NORTH PLAINS, Ore., July 14, 2022 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the third quarter and nine-month periods of fiscal 2022 ended May 31, 2022. Sales for the third quarter of fiscal 2022 totaled approximately...
Zoomd Provides Management Update
VANCOUVER, BC, July 7, 2022 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, today announced...
INVO Bioscience Announces “Get to Know INVOcell” – a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment
Mark Your Calendars for July 7, 2022, with Dr. Sue Ellen Carpenter of Atlanta-based Bloom Fertility SARASOTA, Fla., July 7, 2022 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to...
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
PORTLAND, Maine, July 07, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)
Webinar Featuring Dr. Charles Brenner LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced that it will host a key opinion leader (KOL) webinar on the transforming benefits of nicotinamide riboside (NR) on Wednesday, July 20, 2022 at 11:00 am Eastern Time. The...
PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO
Company Previously Announced Planned CEO Transition Following Retirement of Amir WeisbergPETACH TIKVA, Israel, July 05, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, announced...
Kiora Pharmaceuticals Announces First Patient Enrolled in Phase 2 Study Evaluating KIO-201 for Persistent Corneal Epithelial Defects
Salt Lake City, Utah--(July 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced enrolling the first patient as a part of a Phase 2 study evaluating KIO-201 topical eye drops in patients with Persistent Corneal Epithelial...
Aytu BioPharma Announces the Appointment of Vivian Liu to the Company’s Board of Directors
ENGLEWOOD, CO / June 29, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the appointment of Vivian Liu to the company's board of directors, effective July 1, 2022. Ms....
Mogo Announces Results of Its Annual Meeting of Shareholders
VANCOUVER, British Columbia - The annual general meeting of shareholders (the "Meeting") of Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, was held today via live audiocast online and the Company is...
Kiora Pharmaceuticals Receives Clinical Trial Approval for First-in-Human Evaluation of KIO-301 to Restore Vision in Patients with Retinitis Pigmentosa
Salt Lake City, Utah--(June 27, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") received approval to initiate a first-in-human clinical trial for KIO-301, which is intended to restore lost vision in patients with Retinitis...
LiqTech Announces Closing of Private Placement of $6 Million Senior Notes and Repayment of Outstanding Convertible Note
BALLERUP, Denmark, June 23, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech" or the "Company"), a clean technology company that manufactures and markets highly specialized filtration technologies, announced today that it has completed a private placement...
ARIANNE PHOSPHATE ANNOUNCES ELECTION RESULTS OF ITS 2021 ANNUAL GENERAL MEETING
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, June 22, 2022 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project in...
Specifically Designed to Eliminate Roof Rats in Elevated Spaces – the New EPA-Registered Elevate Bait System™ with ContraPest® Is Now Available for Sale.
"Love is in the air" - a single pair of breeding rats can account for generations of rats; as many as 15,000 after just one year. ContraPest, the EPA-registered birth control for rats, can now be deployed in elevated indoor spaces to combat rising roof rat populations...
ARIANNE PHOSPHATE RECEIVES POSITIVE RESULTS FROM TESTS SURROUNDING THE USE OF ITS CONCENTRATE IN ADVANCED BATTERY APPLICATONS
-successful results will allow the Company to target markets beyond fertilizer DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QUEBEC, June 21, 2022 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a...
PolyPid Hosting Key Opinion Leader Webinar on Managing the Cost of Surgical Site Infections
PETACH TIKVA, Israel, June 15, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a key opinion leader ("KOL") webinar on the cost of managing surgical...
ChromaDex to Present at American Society for Nutrition (ASN), International Society of Sports Nutrition (ISSN), and Federation of American Societies for Experimental Biology (FASEB)
As a pioneer of nicotinamide adenine dinucleotide (NAD+) and healthy aging research, ChromaDex aims to raise awareness amongst industry leaders LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced that members of its team, a Scientific Advisory Board member and...
InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management
The Company will offer Ventis Pharma's patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national...
Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference
ENGLEWOOD, CO / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the company will be participating in the Lytham Partners Summer 2022 Investor Conference...
Scientific Industries Integrates Important New Features into its VIVID Pill Counting Solution to Deliver Digitally Simplified Pharmacy Automation
BOHEMIA, NY / June 10, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer and provider of digitally simplified bioprocessing and pharmacy automation products, announced the release of its newly redesigned VIVID®...
ChromaDex Signs Sinopharm Xingsha Agreement to Accelerate Cross-Border Sales of Tru Niagen® into Mainland China
Under the distribution agreement, all cross-border operations in the region will be transitioned to Sinopharm, with Sinopharm investments to amplify Tru Niagen® brand awareness, as a first step in ChromaDex's recently announced China Joint Venture agreement LOS...
ARIANNE PHOSPHATE APPOINTS MICHAEL GENTILE, CFA AS A STRATEGIC ADVISOR TO THE COMPANY
DAN: TSX-V (Canada) JE9N: FSE (Germany) DRRSF: OTC (USA) SAGUENAY, QC, June 9, 2022 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing its Lac à Paul project...
ChromaDex to Present at the Oppenheimer’s 22nd Annual Consumer Growth and E-Commerce Conference
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting at Oppenheimer's 22nd Annual Consumer Growth and E-Commerce Conference. The ChromaDex management team...
PolyPid Announces Presentation of D-PLEX Phase 2 Clinical Data at ASM Microbe 2022
Phase 2 clinical data on the efficacy of D-PLEX100 in surgical site infection prevention in elective colorectal surgery will be presented during a poster presentation PETACH TIKVA, Israel, June 06, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a...
Modular Medical to Present at LD Micro Invitational XII Investor Conference
SAN DIEGO, CA / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...